(BSX) - Analyzing Boston Scientific's Short Interest
Is Boston Scientific Stock Outperforming the Dow?
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $95
Piper Sandler Sticks to Their Buy Rating for Boston Scientific (BSX)
Boston Scientific Corporation's (NYSE:BSX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
10 Health Care Stocks With Whale Alerts In Today's Session
Boston Scientific's (NYSE:BSX) Returns Have Hit A Wall
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Ventyx Biosciences (VTYX)
Needham Reiterates Hold on Boston Scientific
Boston Scientific Analyst Ratings
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors
International Expansion Supports BSX Stock Amid Macroeconomic Woes
BSX Stock Set to Gain From Agreement to Acquire Intera Oncology
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Boston Scientific Shares Positive Acurate Prime XL TAVR Data
Express News | Boston Scientific Corp: Specific Terms of Transaction Have Not Been Disclosed
Express News | Boston Scientific Corp - Transaction Expected to Be Dilutive on Gaap Basis in 2025
Express News | Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.